102 related articles for article (PubMed ID: 11511823)
1. Screening for cervical cancer in HIV-infected women receiving care in the United States.
Stein MD; Cunningham WE; Nakazono T; Turner BJ; Andersen RM; Bozzette SA; Shapiro MF;
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):463-6. PubMed ID: 11511823
[TBL] [Abstract][Full Text] [Related]
2. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of cervical cancer screening of HIV-infected women in the United States.
Oster AM; Sullivan PS; Blair JM
J Acquir Immune Defic Syndr; 2009 Aug; 51(4):430-6. PubMed ID: 19474756
[TBL] [Abstract][Full Text] [Related]
4. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
[TBL] [Abstract][Full Text] [Related]
6. Assessment of factors impacting cervical cancer screening among low-income women living with HIV-AIDS.
Ogunwale AN; Coleman MA; Sangi-Haghpeykar H; Valverde I; Montealegre J; Jibaja-Weiss M; Anderson ML
AIDS Care; 2016; 28(4):491-4. PubMed ID: 26493859
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
8. Patient-provider communication with HIV-positive women about abnormal Pap test results.
Wigfall LT; Bynum SA; Friedman DB; Brandt HM; Richter DL; Glover SH; Hébert JR
Women Health; 2017 Jan; 57(1):19-39. PubMed ID: 26886433
[TBL] [Abstract][Full Text] [Related]
9. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
Momberg M; Botha MH; Van der Merwe FH; Moodley J
BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
[TBL] [Abstract][Full Text] [Related]
10. Screening for Human Papillomavirus-Associated Cervical Disease in HIV-Infected Women.
Keller MJ
Top Antivir Med; 2015; 23(4):142-5. PubMed ID: 26713504
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system.
Barnes A; Betts AC; Borton EK; Sanders JM; Pruitt SL; Werner C; Bran A; Estelle CD; Balasubramanian BA; Inrig SJ; Halm EA; Skinner CS; Tiro JA
AIDS; 2018 Aug; 32(13):1861-1870. PubMed ID: 29762164
[TBL] [Abstract][Full Text] [Related]
12. Physician recommendation for papanicolaou testing among U.S. women, 2000.
Coughlin SS; Breslau ES; Thompson T; Benard VB
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
14. Present standards for cervical cancer screening.
O'Meara AT
Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269
[TBL] [Abstract][Full Text] [Related]
15. Family planning provider referral, facilitation behavior, and patient follow-up for abnormal Pap smears.
Felix HC; Bronstein J; Bursac Z; Stewart MK; Foushee HR; Klapow J
Public Health Rep; 2009; 124(5):733-44. PubMed ID: 19753952
[TBL] [Abstract][Full Text] [Related]
16. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
Guo F; Hirth JM; Berenson AB
Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
[TBL] [Abstract][Full Text] [Related]
18. False-negative Pap test rate high.
Newsline People AIDS Coalit N Y; 1999; ():31. PubMed ID: 11367341
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
20. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
